Patients have suffered long enough with therapeutic options that bring little relief. It’s time we explore this new world of options so we can begin helping them truly heal.
The research can’t be denied:
These findings are just the beginning. New research findings are coming out regularly that support the use of psychedelic medicines for several difficult-to-treat mental and physical conditions.
The Psychedelic Medicine Association has created a course to help get you up to speed with a psychedelic medicine that's rapidly growing in legal use: psilocybin.
Managing Medical Risk In Patients Seeking Psilocybin Therapy
We are excited to offer a CME/CE accredited course to provide healthcare professionals with the tools they need to safely, effectively, and comfortably assess and discuss the relevant medical risks with their patients.
In this course, you will:
Become a member of The Psychedelic Medicine Association to gain access to a variety of educational and informational tools to help you feel confident to discuss psychedelic medicines with your patients. As a member, you’ll also be connected with like-minded health professionals and the organizations shaping the psychedelic industry.
There was a problem reporting this post.
Please confirm you want to block this member.
You will no longer be able to:
Please allow a few minutes for this process to complete.